Gemigliptin, Dapagliflozin, Empagliflozin DDI Study

Clinical trial NCT03565458 · UNKNOWN

Trial details

NCT number: NCT03565458
Sponsor: LG Chem
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2018-04-05
Primary completion: 2018-08-20
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.